• Welcome

    The NCCR TransCure studies membrane transporters relevant to human diseases by combining the expertise in physiology, structural biology and chemistry.

  • Education

    The NCCR TransCure offers to the fellows an excellent scientific training in a multidisciplinary environment.

  • Equal Opportunities

    The NCCR TransCure supports the career of woman scientists and equal opportunities for researchers.

  • Technology Transfer

    The NCCR TransCure supports the development of the translational components of the projects.

  • Communication

    The NCCR TransCure supports communication within academia and the dialogue with the general public.

Events

Upcoming events

August 12, 2022, Bern
Launch of the learning path "Vitaport - what our body transports"

August 16, 2022, Bern
NCCR TransCure Last Annual Retreat

August 17-19, 2022, Bern
NCCR TransCure Final Conference
 

Aug 30, Sept 13/20/27, 2022, Bern
Vitaport public seminars at Botanical Garden
 

September 7, 2022, Bern
NCCR TransCure Lecture in Biology 
Graham Ladds, University of Cambridge, UK

September 10, 2022, Bern
Night of Research of the University of Bern

 

NCCR TransCure events and courses

Do you know who is the sweetest partner of the @NCCR_TransCure Final Conference? Answer: @ChocolatVillars - Swiss… https://t.co/NM66bfo2rH

To our great Sponsors - a Big Thank You! Final NCCR TransCure Conference on Aug. 17-19, 2022 in Bern @uniofbern!… https://t.co/v2EGFNW4BB

u Retweet

RT @SwissIonChannel: At @NCCR_TransCure Final Conference, with my coll. Prof. C. Peinelt, we will co-chair a session on #IonChannels. What…

Latest publications & news

From our groups:  

Bosshart PD, Kalbermatter D, Bonetti S & Fotiadis D, The making of a potent L-lactate transport inhibitor, Communications Chemistry volume 4, Article number: 128 (2021)  

 

See also the NCCR TransCure Publication List.

 

 

Newsletter

Newsletter

The NCCR TransCure newsletter appears twice a year and informs about projects, fellows, publications and events. Subscribe to the newsletter!

 

Highlights of issue #17:
Research: Synendos Therapeutics 
NCCR network: new LS2 section
How it works: Nanobodies as therapeutics